Capula Management LTD Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Capula Management LTD

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $204,817 - $240,352	200 New	200 $210,000
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $180,538 - $198,670	200 New	200 $192,000
Q3 2023 Nov 03, 2023	BUY	$692.45 - $844.37 $1.38 Million - $1.69 Million	2,000 New	2,000 $1.65 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $9.6 Million - $12.9 Million	-17,500 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$595.12 - $698.43 $10.4 Million - $12.2 Million	17,500 New	17,500 $12.2 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $6.34 Million - $7.48 Million	-13,400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $5.99 Million - $7.35 Million	13,400 New	13,400 $6.34 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.